A nationwide survey of hepatitis C services provided by drug treatment programs

Shiela M. Strauss, Gregory P. Falkin, Zdravko Vassilev, Don Des Jarlais, Janetta Astone

Research output: Contribution to journalArticle

Abstract

Drug treatment programs are a site of opportunity for the delivery of primary and secondary hepatitis C (HCV) prevention services to drug users, a population at great risk for contracting and transmitting the virus. Using data collected from a random nationwide sample (N = 439) of drug treatment programs in the United States, this study examines the extent to which various types of HCV services are provided to their patients. Findings indicate that the majority of drug treatment programs educate at least some of their patients about HCV, and provide some type of support for patients who are infected with the virus. Only 29 of the programs in the sample test all of their patients for HCV, however, and 99 programs test none of them. For the most part, residential treatment programs offer more HCV related services than outpatient drug-free programs.

Original languageEnglish (US)
Pages (from-to)55-62
Number of pages8
JournalJournal of Substance Abuse Treatment
Volume22
Issue number2
DOIs
StatePublished - 2002

Fingerprint

Hepatitis C
Pharmaceutical Preparations
Residential Treatment
Viruses
Therapeutics
Ambulatory Care
Drug Users
Surveys and Questionnaires

Keywords

  • Disease prevention
  • Drug treatment programs
  • HCV services
  • Telephone survey
  • Treatment modality

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

A nationwide survey of hepatitis C services provided by drug treatment programs. / Strauss, Shiela M.; Falkin, Gregory P.; Vassilev, Zdravko; Des Jarlais, Don; Astone, Janetta.

In: Journal of Substance Abuse Treatment, Vol. 22, No. 2, 2002, p. 55-62.

Research output: Contribution to journalArticle

Strauss, Shiela M. ; Falkin, Gregory P. ; Vassilev, Zdravko ; Des Jarlais, Don ; Astone, Janetta. / A nationwide survey of hepatitis C services provided by drug treatment programs. In: Journal of Substance Abuse Treatment. 2002 ; Vol. 22, No. 2. pp. 55-62.
@article{6e5ddcd1c2ed4744a7c419b51ab02603,
title = "A nationwide survey of hepatitis C services provided by drug treatment programs",
abstract = "Drug treatment programs are a site of opportunity for the delivery of primary and secondary hepatitis C (HCV) prevention services to drug users, a population at great risk for contracting and transmitting the virus. Using data collected from a random nationwide sample (N = 439) of drug treatment programs in the United States, this study examines the extent to which various types of HCV services are provided to their patients. Findings indicate that the majority of drug treatment programs educate at least some of their patients about HCV, and provide some type of support for patients who are infected with the virus. Only 29 of the programs in the sample test all of their patients for HCV, however, and 99 programs test none of them. For the most part, residential treatment programs offer more HCV related services than outpatient drug-free programs.",
keywords = "Disease prevention, Drug treatment programs, HCV services, Telephone survey, Treatment modality",
author = "Strauss, {Shiela M.} and Falkin, {Gregory P.} and Zdravko Vassilev and {Des Jarlais}, Don and Janetta Astone",
year = "2002",
doi = "10.1016/S0740-5472(01)00213-6",
language = "English (US)",
volume = "22",
pages = "55--62",
journal = "Journal of Substance Abuse Treatment",
issn = "0740-5472",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - A nationwide survey of hepatitis C services provided by drug treatment programs

AU - Strauss, Shiela M.

AU - Falkin, Gregory P.

AU - Vassilev, Zdravko

AU - Des Jarlais, Don

AU - Astone, Janetta

PY - 2002

Y1 - 2002

N2 - Drug treatment programs are a site of opportunity for the delivery of primary and secondary hepatitis C (HCV) prevention services to drug users, a population at great risk for contracting and transmitting the virus. Using data collected from a random nationwide sample (N = 439) of drug treatment programs in the United States, this study examines the extent to which various types of HCV services are provided to their patients. Findings indicate that the majority of drug treatment programs educate at least some of their patients about HCV, and provide some type of support for patients who are infected with the virus. Only 29 of the programs in the sample test all of their patients for HCV, however, and 99 programs test none of them. For the most part, residential treatment programs offer more HCV related services than outpatient drug-free programs.

AB - Drug treatment programs are a site of opportunity for the delivery of primary and secondary hepatitis C (HCV) prevention services to drug users, a population at great risk for contracting and transmitting the virus. Using data collected from a random nationwide sample (N = 439) of drug treatment programs in the United States, this study examines the extent to which various types of HCV services are provided to their patients. Findings indicate that the majority of drug treatment programs educate at least some of their patients about HCV, and provide some type of support for patients who are infected with the virus. Only 29 of the programs in the sample test all of their patients for HCV, however, and 99 programs test none of them. For the most part, residential treatment programs offer more HCV related services than outpatient drug-free programs.

KW - Disease prevention

KW - Drug treatment programs

KW - HCV services

KW - Telephone survey

KW - Treatment modality

UR - http://www.scopus.com/inward/record.url?scp=0036202472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036202472&partnerID=8YFLogxK

U2 - 10.1016/S0740-5472(01)00213-6

DO - 10.1016/S0740-5472(01)00213-6

M3 - Article

C2 - 11932130

AN - SCOPUS:0036202472

VL - 22

SP - 55

EP - 62

JO - Journal of Substance Abuse Treatment

JF - Journal of Substance Abuse Treatment

SN - 0740-5472

IS - 2

ER -